Table 5

RR for exacerbations during follow-up according to different severity scores

CohortScoresRR—mildRR—moderateRR severe
Dundee,
Scotland (n=494)		BSI0.66 (0.53 to 0.82)*1.00 (reference)2.14 (1.84 to 2.50)*
FACED0.91 (0.77 to 1.06)1.00 (reference)1.44 (1.15 to 1.80)*
Galway,
Ireland (n=280)		BSI0.70 (0.55 to 0.88)1.00 (reference)1.44 (1.16 to 1.78)*
FACED0.74 (0.59 to 0.92)*1.00 (reference)1.25 (0.82 to 1.92)
Monza,
Italy (n=250)		BSI0.76 (0.59 to 0.99)*1.00 (reference)1.38 (1.11 to 1.70)*
FACED1.06 (0.86 to 1.31)1.00 (reference)1.64 (1.24 to 2.17)*
Leuven,
Belgium (n=190)		BSI0.78 (0.52 to 1.18)1.00 (reference)2.08 (1.52 to 2.84)*
FACED0.86 (0.64 to 1.14)1.00 (reference)1.51 (1.05 to 2.16)*
Athens,
Greece (n=159)		BSI0.67 (0.34 to 1.33)1.00 (reference)1.92 (1.21 to 3.04)*
FACED1.20 (0.73 to 1.96)1.00 (reference)2.36 (1.33 to 4.21)*
Newcastle,
England (n=126)		BSI0.47 (0.32 to 0.71)*1.00 (reference)1.29 (1.02 to 1.65)*
FACED0.81 (0.63 to 1.04)1.00 (reference)0.95 (0.64 to 1.41)
Vojvodina,
Serbia (n=113)		BSI0.14 (0.05 to 0.38)*1.00 (reference)2.61 (1.69 to 4.04)*
FACED0.22 (0.13 to 0.37)*1.00 (reference)0.93 (0.49 to 1.77)
Pooled cohort (n=1612)BSI0.63 (0.52 to 0.78)*1.00 (reference)1.73 (1.42 to 2.12)*
FACED0.78 (0.60 to 1.01)1.00 (reference)1.40 (1.16 to 1.68)*

  • *Indicates statistical significance at p<0.05. Pooled data were obtained through random effects meta-analysis.

  • BSI, Bronchiectasis Severity Index; RR, rate ratio.